Supernus Pharmaceuticals (SUPN) Acquisitions (2020)
Supernus Pharmaceuticals (SUPN) posted quarterly Acquisitions of $1.3 million for Q4 2020, down 99.55% on a QoQ basis from $299.5 million in Q2 2020.
Supernus Pharmaceuticals (SUPN) Acquisitions (2020) Analysis & Trends
Supernus Pharmaceuticals has reported Acquisitions for 1 years, with the latest figure at $1.3 million in Q4 2020.
- Acquisitions for Q4 2020 came in at $1.3 million, changed N/A year-over-year; the trailing twelve-month figure through Sep 2022 was $1.3 million (changed 0.0% YoY), and the FY2025 annual result was $293.1 million, changed N/A from the prior year.
- Acquisitions fell to $1.3 million in Q4 2020, from $299.5 million in the prior quarter.
- Over five years, Acquisitions peaked at $299.5 million in Q2 2020 and troughed at $1.3 million in Q4 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Acquisitions (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.07 Bn | 39.42 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.53 Bn | 29.85 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn | - |
| 5 | United Therapeutics | 22.13 Bn | 19.47 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.53 Bn | 15.14 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.97 Bn | - | - |
| 10 | Supernus Pharmaceuticals | 2.75 Bn | 2.37 Bn | 185.39 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2020 | 1.34 Mn |
| Jun 9, 2020 | 297.20 Mn |